No definition available.
Mature T/NK-cell lymphomas, hilmo, excluding all cancers
CD2_TNK_LYMPHOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- C81-C96
- Name in latin
- Lymphomata T-cellularia peripherica et cutanea
Similar endpoints
↥List of similar endpoints to
Mature T/NK-cell lymphomas, hilmo, excluding all cancers
based on the number of shared cases.
Similar with more cases:
- Mature T/NK-cell lymphomas, hilmo
- Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 458 | 166 | 292 |
| Unadjusted period prevalence (%) | 0.10 | 0.06 | 0.13 |
| Median age at first event (years) | 65.19 | 64.58 | 65.53 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 415
- Matched controls
- 4148
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
218.7
190
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
156.3
188.3
189
22
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
120.9
110
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
19.6
102.2
165
135
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
99.0
91
*
L03AA02
ATC
filgrastim; parenteral
1093.8
92.5
87
*
JN4BD
NOMESCO Finland
Extensive body CT
21.4
89.9
138
94
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
74.2
69
*
9700/3-C44.9
ICD-O-3
Mycosis fungoides of skin, NOS
+∞
73.1
68
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
70.9
66
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
68.7
64
*
XW000
NOMESCO Finland
Bone marrow biopsy
23.6
68.4
100
55
A03FA01
ATC
metoclopramide; systemic, rectal
9.7
63.0
142
210
A04AA02
ATC
granisetron; systemic, transdermal
+∞
58.8
55
*
WW500
NOMESCO Finland
Blood transfusion
30.2
57.2
77
31
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
14.9
55.2
96
82
L30.9
ICD-10 Finland
Dermatitis, unspecified
6.2
49.1
158
376
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
47.8
45
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
176.0
45.8
47
*
D07AB08
ATC
desonide; topical
7.5
44.0
114
198
JN4AD
NOMESCO Finland
Body CT examination
14.5
43.2
75
62
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
75.4
42.0
47
7
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
+∞
41.3
39
*
H02AB02
ATC
dexamethasone; systemic
33.5
40.7
53
18
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
22.3
39.6
58
30
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
39.2
37
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.8
38.9
108
204
A04AA01
ATC
ondansetron; systemic, rectal
23.3
38.2
55
27
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
+∞
38.1
36
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
13.6
36.6
65
56
E0000UV
ATC
NA
3.8
36.2
227
993
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
+∞
36.0
34
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.7
35.8
50
22
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
17.9
34.9
55
35
R50.9
ICD-10 Finland
Fever, unspecified
5.5
34.9
116
272
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
101.3
34.3
37
*
L26
ICD-10 Finland
Exfoliative dermatitis
+∞
32.7
31
*
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
+∞
32.7
31
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
32.7
31
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
78.4
32.4
36
5
H02AB06
ATC
prednisolone; systemic
3.5
32.4
269
1425
D70.82
ICD-10 Finland
Drug-induced neutropenia
76.0
31.4
35
5
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
30.6
29
*
D07AD01
ATC
clobetasol; topical
4.5
30.1
122
348
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
312.6
29.2
29
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.6
29.0
71
109
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
+∞
28.5
27
*
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
28.5
27
*
Z51.5
ICD-10 Finland
Palliative care
18.1
28.3
44
27
WF002
NOMESCO Finland
Radical radiotherapy
83.6
28.2
31
*
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
28.8
27.6
37
14
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
27.4
26
*
WW409
NOMESCO Finland
Other aferesis
+∞
26.3
25
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
276.8
26.0
26
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
276.8
26.0
26
*
D07AC01
ATC
betamethasone; topical
3.1
25.9
206
994
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
11.9
25.3
47
44
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
25.3
24
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
96.0
25.0
27
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
138.3
24.9
26
*
9700/3-C44.5
ICD-O-3
Mycosis fungoides of skin of trunk
+∞
24.2
23
*
C84.1
ICD-10 Finland
Sézary disease
+∞
24.2
23
*
M04AA01
ATC
allopurinol; systemic
3.9
23.7
113
365
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
23.1
22
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
23.1
22
*
D05BB02
ATC
acitretin; oral
10.6
22.4
44
46
JN6AD
NOMESCO Finland
CT of torso and neck
55.2
22.3
26
5
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
66.3
22.1
25
*
D07AC13
ATC
mometasone; topical
3.0
22.0
167
757
ZX120
NOMESCO Finland
Intravenous
5.4
21.8
69
147
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
231.6
21.8
22
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
231.6
21.8
22
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
121.4
21.8
23
*
E000001
ATC
NA
3.3
21.5
128
490
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
21.0
20
*
130
Kela drug reimbursment
Malignant tumour
+∞
21.0
20
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
115.8
20.8
22
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
115.8
20.8
22
*
N02AA05
ATC
oxycodone; systemic
4.2
20.4
85
241
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
19.9
19
*
L01AA02
ATC
chlorambucil; oral
+∞
19.9
19
*
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
209.5
19.7
20
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
19.5
222
1264
127
Kela drug reimbursment
Transplant complication
17.8
19.5
30
18
134
Kela drug reimbursment
General erythroderma
48.5
19.4
23
5
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
18.9
18
*
9705/3-C77.9
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph node, NOS
+∞
18.9
18
*
C10AB05
ATC
fenofibrate; oral
11.8
18.6
34
31
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
18.3
81
241
WZC30
NOMESCO Finland
Teaching
4.2
18.1
73
199
1XX25
NOMESCO Finland
NA
+∞
17.8
17
*
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
17.8
17
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
99.3
17.7
19
*
TQW80
NOMESCO Finland
Local dermatologic skincare
10.2
17.2
34
36
XX3DW
NOMESCO Finland
Time consuming IT work
6.4
17.2
46
79
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
16.8
16
*
J01MA12
ATC
levofloxacin; systemic
3.1
16.7
105
408
D02AE01
ATC
carbamide; topical
4.9
16.6
56
127
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
176.7
16.6
17
*
H02AB07
ATC
prednisone; oral
3.3
16.2
90
320
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
7.9
16.1
37
51
E000002
ATC
NA
3.8
16.0
72
216
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.1
16.0
30
29
J05AB11
ATC
valaciclovir; oral
3.4
15.8
83
283
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
14.9
131
621
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
14.7
14
*
H02AB09
ATC
hydrocortisone; systemic
9.7
14.4
29
32
J02AC01
ATC
fluconazole; systemic
2.4
14.2
150
781
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
13.9
95
384
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
13.7
144
748
115
Kela drug reimbursment
Breast cancer
+∞
13.6
13
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
13.6
13
*
ZX196
NOMESCO Finland
NA
+∞
13.6
13
*
HA1AA
NOMESCO Finland
X-ray mammography
8.3
13.3
29
37
D07AB02
ATC
hydrocortisone butyrate; topical
2.4
13.2
137
701
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
29.4
13.1
17
6
ZX112
NOMESCO Finland
Subcutaneous
19.8
13.0
19
10
XQ848
NOMESCO Finland
Dermatological photography
9.5
12.9
26
29
A07AA02
ATC
nystatin; oral
4.7
12.6
43
99
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.5
12.6
61
194
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
12.6
12
*
WW402
NOMESCO Finland
Leucoferesis
+∞
12.6
12
*
9702/3-C77.8
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
12.6
12
*
9700/3-C44.7
ICD-O-3
Mycosis fungoides of skin of lower limb and hip
+∞
12.6
12
*
A02BC02
ATC
pantoprazole; systemic
2.2
12.4
281
2037
L04AD01
ATC
ciclosporin; systemic
10.1
12.4
24
25
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
5.3
12.4
38
78
E000006
ATC
NA
4.1
12.4
49
131
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.2
12.1
29
43
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.3
12.0
64
219
HAB40
NOMESCO Finland
Wedge excision of mammary gland
31.0
11.7
15
5
L41.9
ICD-10 Finland
Parapsoriasis, unspecified
66.9
11.7
13
*
D07AA02
ATC
hydrocortisone; topical
2.9
11.5
74
287
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
11.5
11
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
+∞
11.5
11
*
116
Kela drug reimbursment
Prostate cancer
+∞
11.5
11
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
+∞
11.5
11
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
11.5
11
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
11.5
11
*
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
5.4
11.5
34
67
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.7
11.5
24
29
A41.9
ICD-10 Finland
Sepsis, unspecified
6.0
11.4
31
55
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.9
11.1
36
79
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.1
11.0
24
31
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.4
10.9
28
46
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
18.4
10.8
16
9
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
28.9
10.8
14
5
JN4CD
NOMESCO Finland
Very extensive body CT
8.3
10.7
23
29
L20.0
ICD-10 Finland
Besnier prurigo
4.9
10.6
34
74
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
112.7
10.5
11
*
L41.8
ICD-10 Finland
Other parapsoriasis
112.7
10.5
11
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
10.5
10
*
B72
ICPC
Hodgkin Lymphoma
+∞
10.5
10
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
10.5
10
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
10.5
10
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
10.5
10
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
10.5
10
*
S18
ICPC
Laceration/cut
2.0
10.0
182
1168
E000003
ATC
NA
4.3
10.0
37
93
D02AX
ATC
Other emollients and protectives
5.9
10.0
27
48
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
12.6
9.9
17
14
JFB00
NOMESCO Finland
Partial resection of small intestine
12.6
9.9
17
14
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
13.8
9.7
16
12
L04AA06
ATC
mycophenolic acid; systemic
9.4
9.6
19
21
D69.5
ICD-10 Finland
Secondary thrombocytopenia
102.2
9.5
10
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
9.4
9
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
9.4
9
*
L01CB01
ATC
etoposide; systemic
+∞
9.4
9
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
9.4
9
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
9.4
50
171
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
14.1
9.2
15
11
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.3
9.2
33
81
A05AA02
ATC
ursodeoxycholic acid; oral
10.4
9.1
17
17
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
37.5
9.1
11
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.7
9.0
20
27
D70.89
ICD-10 Finland
Neutropenic splenomegaly
19.1
9.0
13
7
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
12.9
8.9
15
12
TGC00
NOMESCO Finland
Bronchial lavation
5.6
8.9
25
47
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.4
8.8
31
75
L57.0
ICD-10 Finland
Actinic keratosis
3.2
8.8
46
156
J01DB01
ATC
cefalexin; oral
2.0
8.7
322
2622
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
51.1
8.7
10
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
51.1
8.7
10
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
8.5
8.7
18
22
L04AA01
ATC
[U] ciclosporin; systemic
11.9
8.6
15
13
TQW99
NOMESCO Finland
Other minor procedure on skin
5.4
8.6
25
49
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.8
8.6
54
207
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
8.5
99
523
E000007
ATC
NA
4.1
8.5
32
83
L41.4
ICD-10 Finland
Large plaque parapsoriasis
91.8
8.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
91.8
8.4
9
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
91.8
8.4
9
*
J02AC03
ATC
voriconazole; systemic
+∞
8.4
8
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
+∞
8.4
8
*
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
8.4
8
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
8.4
8
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
8.3
42
139
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
7.8
8.2
18
24
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
8.2
106
585
TK800
NOMESCO Finland
Hemodialysis
5.9
7.9
21
37
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.5
7.7
64
287
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
25.5
7.6
10
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
7.6
120
716
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.1
7.5
42
147
ZXC50
NOMESCO Finland
Cryotherapy
6.7
7.5
18
28
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.7
7.5
51
205
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
7.5
44
162
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
7.9
7.5
16
21
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
81.5
7.4
8
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
81.5
7.4
8
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
13.7
7.4
12
9
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
7.4
190
1332
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
9.6
7.3
14
15
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
7.3
7
*
9717/3-C17.9
ICD-O-3
Intestinal T-cell lymphoma of small intestine, NOS
+∞
7.3
7
*
9700/3-C44.6
ICD-O-3
Mycosis fungoides of skin of upper limb and shoulder
+∞
7.3
7
*
C84
ICD-10 Finland
Mature T/NK-cell lymphomas
+∞
7.3
7
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
7.3
7
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
7.3
7
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
7.3
7
*
C84.42
ICD-10 Finland
Peripheral T-cell lymphoma, both medium and large cell type
+∞
7.3
7
*
C84.2
ICD-10 Finland
T-zone lymphoma
+∞
7.3
7
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
C83.52
ICD-10 Finland
T-lymphoblastic lymphoma or leukemia
+∞
7.3
7
*
C84.3
ICD-10 Finland
Lymphoepithelioid lymphoma
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.0
7.3
42
152
ZZR00
NOMESCO Finland
Flap of skin
30.6
7.2
9
*
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.0
7.1
105
605
ZX108
NOMESCO Finland
Inhalation
12.3
7.1
12
10
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
7.1
57
249
H03AA01
ATC
levothyroxine sodium; systemic
2.0
7.0
96
537
GD1AD
NOMESCO Finland
Thorax CT examination
4.5
7.0
23
53
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
6.9
40
146
L03AB05
ATC
interferon alfa-2b; parenteral
40.7
6.8
8
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
40.7
6.8
8
*
RS340
NOMESCO Finland
NA
40.7
6.8
8
*
B01AB10
ATC
tinzaparin; parenteral
3.7
6.7
28
80
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.3
6.7
32
102
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
22.9
6.7
9
*
R06AE07
ATC
cetirizine; oral
1.8
6.7
158
1072
AA1BD
NOMESCO Finland
Extensive CT of head and brain
8.0
6.7
14
18
H26.3
ICD-10 Finland
Drug-induced cataract
12.5
6.6
11
9
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
10.3
6.6
12
12
D07XC01
ATC
betamethasone, combinations; topical
2.3
6.5
61
288
L30.3
ICD-10 Finland
Infective dermatitis
4.2
6.5
23
57
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
70.9
6.4
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
70.9
6.4
7
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
14.6
6.4
10
7
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.4
6.4
29
89
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.5
6.3
21
49
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
18.3
6.3
9
5
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
1AA09
NOMESCO Finland
NA
+∞
6.3
6
*
WF099
NOMESCO Finland
Other radiotherapy
+∞
6.3
6
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
9702/3-C80.9
ICD-O-3
Mature T-cell lymphoma, NOS, of unknown primary site
+∞
6.3
6
*
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
6.3
6
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
9702/3-C42.1
ICD-O-3
Mature T-cell lymphoma, NOS, of bone marrow
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
6.3
6
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
6.3
6
*
9701/3-C44.9
ICD-O-3
Sezary syndrome of skin, NOS
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
9705/3-C77.8
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions
+∞
6.3
6
*
J05AB01
ATC
aciclovir; systemic
2.0
6.3
85
472
N05CF01
ATC
zopiclone; oral
1.8
6.2
141
935
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
27.1
6.2
8
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.1
6.2
33
114
JAH00
NOMESCO Finland
Laparotomy
5.0
6.1
18
37
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
8.8
6.1
12
14
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.3
6.1
17
33
R4190
NOMESCO Finland
Nutritional therapy
6.2
6.0
15
25
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
4.4
6.0
20
47
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
102
46
28.24
143.29
5.4
2.8
29322.1
467.1
u/ml
—
28
8
72
11
77.48
133.14
2.3
2.0
—
—
—
0
0
100
58
21.78
125.92
10.1
4.9
438.9
170.7
iu/ml
—
21
6
67
13
60.20
118.53
2.2
1.8
13.0
11.3
%
—
53
7
66
15
51.24
112.88
3.6
1.8
393.5
1257.3
e6/l
—
15
7
66
57
13.36
65.94
1.6
1.3
—
—
—
0
0
65
61
12.25
61.50
4.1
1.3
—
—
—
0
0
65
66
11.31
58.26
3.9
1.3
—
—
—
0
0
330
1548
5.05
57.54
14.3
5.2
56.5
57.8
%
1.07
325
1432
56
47
13.44
56.74
1.6
1.4
179.6
117.8
u/ml
—
10
8
54
46
13.17
54.16
3.8
1.3
—
—
—
0
0
44
27
17.92
52.80
3.6
1.3
—
—
—
0
0
37
17
23.59
50.36
4.6
2.4
34.5
54.3
%
—
10
6
41
25
17.91
49.29
3.8
1.3
—
—
—
0
0
45
33
15.01
49.15
7.0
3.5
2.4
1.4
%
0.41
40
26
347
1840
4.66
47.57
28.7
6.1
3.8
4.4
e9/l
4.67
326
1601
160
497
4.41
47.04
10.9
3.0
0.8
0.8
mmol/l
4.52
155
466
98
222
5.34
42.27
3.3
1.5
—
—
—
0
0
53
63
9.38
42.05
1.5
1.1
—
—
—
0
0
56
90
6.95
34.24
2.3
1.2
—
—
—
0
0
24
10
25.27
33.60
5.3
1.1
—
—
—
0
0
24
10
25.27
33.60
5.3
1.1
—
—
—
0
0
24
10
25.27
33.60
5.3
1.2
—
—
—
0
0
30
21
15.22
33.36
1.7
1.2
—
—
—
0
0
46
61
8.27
33.29
1.4
1.1
351.8
262.0
u/ml
0.66
30
32
37
37
10.79
33.13
2.1
1.3
—
—
—
0
0
32
26
13.16
32.71
4.6
1.1
—
—
—
0
0
32
26
13.16
32.71
4.6
1.1
—
—
—
0
0
32
26
13.16
32.71
4.6
1.1
—
—
—
0
0
275
1470
3.18
32.10
12.8
3.7
33.0
35.5
g/l
8.95
266
1350
209
972
3.12
30.89
7.2
2.5
1709.7
8907.1
umol/l
2.57
200
837
41
54
8.24
29.78
2.4
1.2
—
—
—
0
0
292
1681
3.03
28.68
20.0
4.1
11.3
12.4
umol/l
0.66
286
1564
24
15
16.83
28.18
5.3
1.1
—
—
—
0
0
24
15
16.83
28.18
5.3
1.1
—
—
—
0
0
24
15
16.83
28.18
5.3
1.1
—
—
—
0
0
24
15
16.83
28.18
5.3
1.1
—
—
—
0
0
67
154
4.92
27.93
1.8
1.6
1.7
1.5
g/l
0.63
59
133
35
45
8.34
25.87
1.9
1.2
—
—
—
0
0
27
26
10.97
24.67
8.0
2.7
58.4
51.5
%
0.48
21
20
139
588
2.96
23.25
4.1
1.7
—
—
—
0
0
19
11
17.98
23.02
8.0
2.9
—
—
—
0
0
207
1084
2.66
22.84
8.3
2.0
2.3
2.3
mmol/l
0.52
199
880
45
87
5.63
22.69
2.3
1.4
—
—
—
0
0
28
32
9.25
22.64
2.3
1.4
—
—
—
0
0
40
70
6.17
22.35
3.1
1.1
—
—
—
0
0
21
0
+∞
22.05
1.3
0.0
—
—
—
0
0
26
28
9.78
21.95
1.8
1.5
—
—
—
0
0
99
359
3.24
21.49
9.6
2.5
6.2
7.7
umol/l
0.68
92
312
32
46
7.40
21.47
2.7
1.2
—
—
—
0
0
28
35
8.46
21.11
4.1
2.1
—
—
—
0
0
30
41
7.76
21.02
2.7
1.2
—
—
—
0
0
41
81
5.46
20.16
1.3
2.0
12.9
12.9
mg/l
0.01
34
75
95
351
3.15
19.89
5.0
3.0
—
—
—
0
0
25
31
8.47
18.93
4.0
1.1
—
—
—
0
0
53
138
4.21
18.71
1.3
2.2
43.3
38.5
u/l
0.66
46
120
25
32
8.21
18.45
4.0
1.1
—
—
—
0
0
25
32
8.21
18.45
4.1
1.1
—
—
—
0
0
25
32
8.21
18.45
4.1
1.1
—
—
—
0
0
25
32
8.21
18.45
4.1
1.1
—
—
—
0
0
25
32
8.21
18.45
4.0
1.1
—
—
—
0
0
267
1689
2.39
18.32
17.1
5.7
1.2
1.2
mmol/l
0.45
228
1443
31
53
6.20
17.67
5.3
3.0
53.7
58.5
%
1.04
31
53
23
9
26.80
17.07
2.4
1.0
—
—
—
0
0
23
9
26.80
17.07
2.3
1.0
—
—
—
0
0
240
1483
2.30
16.95
10.4
3.7
—
—
—
0
0
27
43
6.61
16.46
2.7
1.7
34.6
33.7
pg
0.59
27
43
99
413
2.78
16.45
3.1
1.8
—
—
—
0
0
45
114
4.27
16.43
2.7
3.3
—
—
—
0
0
98
411
2.76
16.09
3.3
1.8
—
—
—
0
0
20
6
34.75
15.86
2.6
1.0
—
—
—
0
0
20
6
34.75
15.86
2.5
1.0
—
—
—
0
0
31
61
5.38
15.27
1.5
1.3
—
—
—
0
0
240
1542
2.17
14.71
14.6
5.5
1.2
1.2
mmol/l
0.39
232
1372
59
197
3.29
14.42
1.7
1.2
2467.8
249.2
u/ml
0.67
52
178
43
119
3.88
13.92
1.6
1.2
0.5
0.4
g/l
0.09
38
106
142
764
2.24
13.35
6.7
2.0
—
—
—
0
0
14
13
11.08
12.91
1.4
1.0
—
—
—
0
0
14
13
11.08
12.91
1.3
1.1
—
—
—
0
0
38
103
3.93
12.65
1.5
1.3
73.4
44.4
mg/l
0.90
29
87
38
103
3.93
12.65
1.5
1.3
55.8
32.2
mg/l
1.17
28
88
344
2626
2.25
12.61
7.3
4.0
16.2
12.2
mm/h
3.97
335
2388
73
298
2.72
12.46
3.2
1.6
372.9
368.5
nmol/l
0.06
68
270
66
258
2.82
12.22
3.0
2.0
0.2
0.2
g/l
0.11
61
229
53
183
3.14
12.22
2.1
1.3
3.7
4.4
ug/l
0.14
42
143
123
652
2.21
11.81
9.0
2.1
2.5
2.4
mmol/l
2.84
115
544
44
144
3.27
11.07
1.5
1.3
4.3
4.0
g/l
0.42
33
104
44
144
3.27
11.07
1.5
1.3
—
—
—
0
0
44
144
3.27
11.07
1.5
1.3
7.2
7.6
g/l
0.64
33
108
14
5
28.80
10.78
1.8
1.0
—
—
—
0
0
42
136
3.30
10.74
1.5
1.3
3.3
3.2
g/l
0.28
33
106
15
7
22.09
10.74
7.8
1.0
—
—
—
0
0
194
1264
1.93
10.35
4.3
2.9
—
—
—
0
0
17
28
6.27
9.99
1.2
1.6
—
314.0
—
0
5
43
148
3.10
9.95
5.3
1.5
—
—
—
0
0
127
725
2.04
9.84
2.6
1.7
1.9
1.2
mg/l
2.20
112
565
285
2126
1.90
9.83
9.3
4.4
6.6
6.8
mmol/l
1.01
273
1999
78
368
2.35
9.74
6.1
3.2
1.2
2.1
mmol/l
0.95
66
300
89
448
2.22
9.53
16.7
5.3
104.4
104.2
mmol/l
0.15
89
436
47
178
2.83
9.19
6.3
3.4
24.0
24.3
mmol/l
0.16
47
159
17
31
5.66
9.04
1.2
1.1
—
—
—
0
0
13
18
7.40
8.89
1.3
1.4
—
—
—
0
0
19
40
4.91
8.66
1.2
1.3
—
—
—
0
0
16
30
5.49
8.26
1.4
1.7
—
—
—
0
0
11
5
22.48
8.05
2.6
1.6
—
—
—
0
0
11
14
8.03
8.02
2.4
1.4
—
—
—
0
0
11
14
8.03
8.02
2.4
1.4
—
—
—
0
0
51
218
2.51
7.86
2.4
1.7
—
—
—
0
0
13
21
6.34
7.75
1.2
1.7
—
—
—
0
0
24
67
3.72
7.68
2.5
1.6
35.3
195.8
u/ml
0.65
18
50
12
18
6.82
7.64
2.3
1.3
—
—
—
0
0
14
25
5.75
7.58
2.6
1.4
—
—
—
0
0
149
966
1.80
7.58
4.1
2.8
0.2
0.5
e6/l
5.22
119
720
20
50
4.14
7.42
1.1
1.1
—
—
—
0
0
28
89
3.29
7.39
1.4
1.5
—
—
—
0
0
158
1050
1.77
7.35
7.6
2.7
35.8
38.2
u/l
0.30
151
994
85
463
2.03
7.32
2.8
2.4
23.5
23.4
%
0.01
73
396
36
136
2.79
7.08
2.5
1.4
—
—
—
0
0
35
132
2.79
6.91
1.5
1.5
—
193.3
—
0
9
53
245
2.32
6.89
7.4
3.5
2.3
2.0
mmol/l
0.22
45
182
87
494
1.94
6.63
2.7
2.3
2.2
2.3
g/l
0.48
81
451
12
21
5.84
6.62
1.3
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
101
3.00
6.60
2.7
3.1
0.3
0.4
u/ml
0.11
17
60
29
102
2.97
6.49
1.8
1.2
—
—
—
0
0
29
103
2.94
6.38
1.8
1.2
—
—
—
0
0
40
169
2.50
6.33
8.4
3.9
25.3
24.9
mmol/l
0.29
40
158
94
559
1.86
6.20
3.6
2.8
4.7
2.0
e6/l
0.44
60
299
160
1111
1.68
6.15
3.6
2.2
71.3
56.8
u/l
0.31
150
1018
54
266
2.17
6.03
3.4
3.9
100.5
89.4
ng/l
0.25
49
235
92
552
1.83
5.88
2.8
2.3
12.3
12.9
umol/l
0.26
85
505
135
906
1.69
5.85
2.6
2.2
3.4
3.0
mg/l
0.77
125
763
10
17
5.99
5.65
2.1
1.1
—
—
—
0
0
185
1367
1.59
5.39
2.4
2.2
75.1
77.0
nmol/l
0.41
169
1181
9
8
11.44
5.31
1.1
1.0
—
—
—
0
0
9
8
11.44
5.31
3.0
6.5
—
—
—
0
0
186
1385
1.58
5.20
3.8
2.7
657.6
143.4
ug/l
3.44
172
1261
113
748
1.68
5.08
4.5
4.1
165.4
354.9
ng/l
0.87
95
615
8
7
11.60
4.80
1.0
1.1
—
—
—
0
0
10
20
5.09
4.80
1.2
1.1
—
—
—
0
0
17
52
3.36
4.79
2.1
1.2
25.1
26.8
iu/l
0.07
17
45
33
148
2.33
4.62
1.8
1.3
—
—
—
0
0
115
783
1.63
4.59
1.8
1.7
967.5
1184.8
nmol/l
1.79
94
596
7
5
14.18
4.59
1.4
1.0
—
—
—
0
0
69
409
1.81
4.55
9.8
7.8
11.1
11.4
kpa
0.21
63
397
69
409
1.81
4.55
9.8
7.8
4.7
5.1
kpa
3.17
63
395
7
6
11.82
4.29
1.3
1.0
—
—
—
0
0
68
410
1.77
4.24
9.8
7.8
-0.3
1.4
mmol/l
1.76
51
321
21
79
2.74
4.21
1.2
1.3
—
—
—
0
0
18
63
2.93
4.11
1.7
1.3
72.2
273.7
miu/ml
—
5
25
8
11
7.38
3.87
2.3
1.3
27.6
27.8
umol/l
—
8
11
9
15
6.10
3.83
1.3
1.5
—
—
—
0
0
20
78
2.64
3.77
1.5
1.2
—
—
—
0
0
89
600
1.60
3.65
3.5
2.6
1.1
1.1
e6/l
0.05
56
337
22
92
2.46
3.62
1.6
1.7
—
—
—
0
0
162
1247
1.46
3.58
3.2
3.1
2686.9
1606.3
ng/l
0.57
146
1071
31
152
2.11
3.55
3.0
3.1
4.1
4.4
pmol/l
1.19
26
132
10
27
3.76
3.37
1.1
1.0
—
—
—
0
0
8
14
5.79
3.35
1.3
1.1
—
—
—
0
0
17
66
2.64
3.25
1.7
1.8
—
—
—
0
0
19
79
2.47
3.18
1.4
1.3
—
—
—
0
0
19
79
2.47
3.18
1.4
1.3
—
—
—
0
0
10
29
3.50
3.06
1.4
1.1
—
—
—
0
0
41
235
1.82
3.04
2.3
1.4
—
—
—
0
0
23
108
2.19
2.96
1.9
1.8
—
—
—
0
0
7
13
5.45
2.88
1.9
1.3
213.0
201.4
u/l
—
7
13
6
9
6.74
2.87
7.0
3.3
136.3
76.8
%
—
6
9
11
36
3.11
2.82
1.2
1.6
—
—
—
0
0
8
18
4.50
2.80
1.8
1.4
—
—
—
0
0
10
32
3.17
2.66
1.2
1.1
—
—
—
0
0
17
74
2.35
2.61
1.8
1.2
269.8
302.5
ug/g
0.32
12
38
12
44
2.77
2.56
1.3
1.3
—
—
—
0
0
5
7
7.21
2.55
1.2
1.1
—
—
—
0
0
6
12
5.05
2.41
1.2
1.2
—
—
—
0
0
6
12
5.05
2.41
1.0
1.2
10.1
8.8
ug/l
—
6
12
16
71
2.30
2.37
2.3
1.9
16.1
16.4
%
—
7
33
5
9
5.60
2.22
1.0
1.3
—
—
—
0
0
7
19
3.72
2.16
1.3
1.2
3.0
2.1
mmol/l
—
7
19
189
1595
1.31
2.16
2.2
2.0
88.5
93.9
pmol/l
0.70
122
815
6
14
4.33
2.15
1.3
1.1
—
—
—
0
0
311
3377
0.75
2.07
6.6
6.5
40.3
40.7
mmol/mol
0.31
288
3121
118
937
1.35
2.03
1.8
1.5
17.7
20.4
nmol/l
1.30
101
791
42
274
1.59
2.01
3.2
2.0
67.6
61.2
ml/min/173m2
0.38
17
109
7
23
3.07
1.80
1.0
1.0
—
—
—
0
0
7
24
2.95
1.73
1.0
1.1
—
—
—
0
0
88
685
1.35
1.72
1.3
1.3
1.9
1.5
u/ml
0.24
21
193
5
13
3.88
1.72
1.0
2.1
3.9
4.1
nmol/l
—
5
13
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
13
3.88
1.72
1.4
1.2
—
—
—
0
0
8
31
2.61
1.66
1.3
1.1
—
—
—
0
0
370
3481
1.33
1.60
43.5
13.1
26.2
24.7
mg/l
0.36
342
2697
339
3602
0.77
1.59
6.0
5.4
2.7
2.6
mmol/l
1.00
316
3290
10
44
2.30
1.54
1.0
1.4
—
—
—
0
0
7
28
2.52
1.45
1.4
1.2
—
85.4
—
0
5
10
46
2.20
1.41
1.1
1.0
1.7
1.5
g/l
—
10
39
9
40
2.27
1.41
1.0
1.1
—
—
—
0
0
329
3492
0.79
1.39
5.6
4.8
1.3
1.4
mmol/l
4.96
311
3185
5
17
2.96
1.36
2.4
2.1
—
—
—
0
0
281
2586
1.22
1.31
6.2
3.6
14.6
15.0
pmol/l
2.31
264
2328
9
43
2.11
1.31
1.0
1.1
—
—
—
0
0
9
43
2.11
1.31
2.2
3.7
—
—
—
0
0
8
34
2.38
1.29
1.0
1.0
—
—
—
0
0
12
214
0.55
1.25
3.0
1.7
—
—
—
0
0
70
554
1.31
1.24
25.1
28.2
1.4
1.3
inr
0.13
16
75
192
1708
1.21
1.24
3.9
3.6
0.0
0.0
estimate
0.00
46
264
173
1525
1.22
1.22
4.6
3.9
35.5
47.9
ng/l
1.09
134
1122
10
187
0.52
1.21
1.8
1.6
—
—
—
0
0
189
1682
1.21
1.21
5.3
4.9
0.0
0.0
estimate
0.00
49
268
56
431
1.34
1.20
1.5
1.4
—
—
—
0
0
6
26
2.32
1.19
1.5
1.0
—
—
—
0
0
35
251
1.43
1.14
7.3
8.6
24.3
24.5
mmol/l
0.10
30
238
28
192
1.49
1.14
1.2
1.2
72.4
93.4
iu/ml
—
5
73
335
3522
0.82
1.10
6.6
4.8
4.5
4.5
mmol/l
0.38
320
3236
65
526
1.27
1.00
1.3
1.3
1.0
12.2
u/ml
3.50
29
191
5
23
2.19
0.98
1.6
1.5
0.8
1.0
g/l
—
5
23
99
844
1.22
0.96
1.8
1.8
620.8
5789140.5
pmol/l
0.50
84
691
186
1687
1.17
0.91
4.0
3.5
0.0
0.0
estimate
0.00
48
271
203
1857
1.17
0.89
3.0
2.6
—
—
—
0
0
8
46
1.75
0.83
1.0
1.0
—
—
—
0
0
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
6
33
1.83
0.79
1.2
1.2
—
—
—
0
0
146
1317
1.16
0.75
4.3
3.7
—
—
—
0
0
103
905
1.18
0.74
4.5
3.7
0.0
0.0
estimate
0.50
46
263
237
2216
1.14
0.73
5.9
3.0
76.7
49.1
u/l
2.36
222
2043
122
1359
0.86
0.72
3.9
3.8
20.7
24.0
%
1.43
54
642
7
40
1.76
0.71
1.1
1.3
89.7
57.0
pmol/l
—
7
40
39
484
0.79
0.71
20.0
6.9
—
—
—
0
0
10
64
1.58
0.59
1.3
1.3
—
—
—
0
0
342
3531
0.88
0.58
6.2
4.9
6.0
6.1
mmol/l
0.96
316
3192
380
3895
0.86
0.58
58.6
19.2
4.2
4.5
e12/l
21.16
373
3757
18
239
0.74
0.55
1.6
1.9
—
—
—
0
0
6
38
1.59
0.54
1.2
1.2
—
—
—
0
0
15
111
1.36
0.47
1.5
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
285.0
—
0
6
330
3382
0.91
0.36
6.7
4.3
1.5
1.3
mmol/l
3.84
314
3060
9
122
0.73
0.35
1.2
1.8
40.4
42.1
nmol/l
—
9
117
338
3310
1.08
0.28
34.7
11.9
76.6
76.6
ml/min/173m2
0.01
309
2657
11
140
0.78
0.28
1.0
1.0
—
—
—
0
0
162
1694
0.93
0.28
4.2
3.9
2.4
2.0
ug/l
0.35
147
1511
9
73
1.24
0.25
1.2
1.1
—
—
—
0
0
316
3096
1.07
0.24
37.1
14.5
37.3
39.9
%
4.30
215
2072
10
79
1.27
0.22
1.3
1.4
1.2
0.8
nmol/l
—
10
64
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
89
939
0.94
0.20
2.8
2.7
0.6
0.7
ug/l
0.79
61
632
77
812
0.94
0.17
4.3
3.9
1.0
1.0
kg/l
0.33
11
118
6
78
0.77
0.15
1.2
2.0
—
—
—
0
0
7
89
0.78
0.14
1.0
1.3
—
—
—
0
0
39
366
1.07
0.12
1.7
1.8
1.4
1.6
%
1.78
33
311
59
563
1.06
0.11
1.3
1.3
9.9
36.3
iu/ml
5.85
17
173
128
1312
0.97
0.10
3.8
3.9
9.8
7.6
mg/mmol
0.25
81
827
47
493
0.95
0.10
5.0
4.9
27.5
32.3
%
3.24
42
326
5
48
1.04
0.09
1.2
1.3
0.7
0.6
nmol/l
—
5
42
6
58
1.03
0.08
1.8
1.1
—
—
—
0
0
370
3723
0.97
0.07
43.9
16.2
4.0
4.0
mmol/l
1.70
364
3615
322
3205
1.02
0.03
6.1
4.4
1.9
2.0
mu/l
0.89
304
2886
370
3713
0.98
0.03
43.1
16.1
139.1
139.8
mmol/l
5.57
364
3606
29
300
0.96
0.03
1.9
1.3
—
—
—
0
0
11
102
1.08
0.03
1.8
1.7
7377.8
14326.2
e6/l
0.67
11
75
97
979
0.99
0.01
2.1
1.6
1.7
1.3
mmol/l
2.36
88
800
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
5
51
0.98
0.00
1.8
4.1
324.6
349.0
umol/l
—
5
42
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
108.2
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
23.6
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
0.7
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: CD2_TNK_LYMPHOMA_EXALLC – Mature T/NK-cell lymphomas, hilmo, excluding all cancers
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).